MAPT and Mental deterioration: Although tau PET has been shown to predict cognitive decline in cognitively unimpaired individuals, biomarker-only diagnosis of AD generally has modest predictive accuracy in cognitively unimpaired individuals [11] because these subjects may show amyloid positivity and not display clinical manifestations within their lifetime.